Loading company…
Neurovia, Inc. develops therapies for rare genetic neurological diseases.
Neurovia develops therapies for rare genetic neurological diseases. Established in 2013 and based in San Francisco, California, US, it is listed at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in